Yu Nakagama1, Maria-Virginia Rodriguez-Funes2, Rhina Dominguez3, Katherine-Sofia Candray-Medina4, Naoto Uemura5, Evariste Tshibangu-Kabamba6, Yuko Nitahara6, Natsuko Kaku6, Akira Kaneko6, Yasutoshi Kido7. 1. Department of Virology & Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan; Research Centre for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Electronic address: nakagama.yu@omu.ac.jp. 2. National Rosales Hospital, San Salvador, El Salvador. 3. El Salvador National Institute of Health, San Salvador, El Salvador. 4. Department of Virology & Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan; Research Centre for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan; Centro Nacional de Investigaciones Científicas de El Salvador (CICES), San Salvador, El Salvador. 5. Department of Clinical Pharmacology and Therapeutics, School of Medicine, Oita University, Oita, Japan. 6. Department of Virology & Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan; Research Centre for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. 7. Department of Virology & Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan; Research Centre for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Electronic address: kidoyasu@omu.ac.jp.
To the Editor,The novel COVID-19 pandemic has threatened public health systems worldwide. Its impact, however, has been under-evaluated in most low- and middle-income countries, including regions in Central America [1]. We launched a seroepidemiological survey, extending from end-January to mid-February 2021, at a tertiary care referral hospital located in the capital city of El Salvador, where a large number of confirmed and far more suspected cases of SARS-CoV-2 affected healthcare workers (HCWs) had been documented during the first wave of the pandemic.A total 2322 HCWs from the National Clinical Laboratory and the National Rosales Hospital were recruited, of which 973 individuals (41.9% response rate, aged 43 ± 11 years, 71.7% female) having consented to participate were eligible for analysis. The sites served as the main referral facilities for COVID-19 during May through July 2020. The same level of protection (full length gown, face shield, N95 or higher-level filter mask, and gloves) was mandated for all of the COVID-19 contacts, and training for its use was provided uniformly. During the study period of end-January through mid-February 2021, the participants completed a questionnaire through the web-based REDCap electronic data capture tool [2] and provided sera for serological evaluation. The questionnaire queried about the participants' demographic data, anthropometric measurements, medical history, occupational role, prior COVID-19 diagnosis, and family member contracting COVID-19. The serological status was defined by the combination of two immunoassays: Roche Elecsys Anti-SARS-CoV-2 assay (Basel, Switzerland) and Abbott SARS-CoV-2 IgG II Quant (Chicago, IL, USA). The participants of ‘indeterminate’ serology with discordant results (1.7%, 17 of 973) were excluded from analyses. An χ2 test was used upon comparison and the ‘non-patient–related’ occupations served as reference for risk ratio calculation. The p thresholds of Bonferroni-adjusted 0.017 defined the statistical significance. The research was approved by the Osaka City University Institutional Ethics Committee [#2020-003] and the National Research Ethics Committee of El Salvador [#CNEIS/2020/029].The overall seropositivity rate in HCWs reached 52.6% (512 of 973). Among the seropositive individuals, 61.7% (316 of 512) had experienced documented COVID-19, of which 70.6% (223 of 316) were laboratory-confirmed by PCR (the rest were diagnosed clinically). Finally, those never having been suspected of the diagnosis nor underwent SARS-CoV-2 PCR testing, but still revealed positive for anti-SARS-CoV-2 antibodies, aggregated to the excessive 38.3% (196 of 512) of ‘unrecognized seroconversions.’ Nurses had the highest seropositivity rate of 63.8%, followed by HCWs assigned to other patient-related work (55.9%), and medical doctors (46.7%). Auxiliary HCWs assigned to non-patient–related work, ranking bottom among occupations, still showed surprisingly high seroprevalence (44.2%). Additionally, 21.8% (97 of 444) of seronegative individuals reported of their family member contracting COVID-19.The presented Salvadorian HCW cohort listed highest in seroprevalence (52.6%) among the pooled trend for HCWs globally (4.8% through 12.4%) [3,4], far exceeding that reported from Brazil (29.9%), another Latin American country [5]. The risk of infection per occupation generally reflected their variable degrees of proximity with COVID-19 patients; patient-related work associated with higher risk (see Table 1). Interestingly, however, respiratory care specialists who perform the highly aerosol-generating, endotracheal procedures on COVID-19 patients carried less risk in contracting the disease compared with cleaning staff entering the COVID-19 ward (45.5% vs. 71.9% in seroprevalence). Previous studies targeting HCWs have reported similar traits for cleaning personnel carrying high infection risk [[6], [7], [8]]. A high risk of infection among the cleaning staff has been attributed to their lower adherence to protective measures, due to less understanding about (1) the transmission mechanisms of viral respiratory infections, as well as (2) the proper use of countermeasures to mitigate them. Their circumstances outside the hospital (i.e. socioeconomic factors potentially linked to public transportation use or housing conditions prone to crowd exposure) have also been raised as contributing factors. The same logic may apply to our present cohort. Lastly, our data highlighted the possibility of the current epidemiological estimates having been under-representative of the true regional burden. Under-estimation of COVID-19 burden may be explained by the excessive number of pauci/asymptomatic, thus unrecognized, seroconversions [9]. Seroprevalence among non-patient–related Salvadorian HCWs (44.2%) was highly elevated to exceed twice the community seroprevalence in United States at the time (18.4%) [10]. Together with the high frequency (21.8%) of seronegative individuals in this study reporting of household COVID-19 cases, our findings in total were indicative of substantial transmission having occurred in the communities, potentially outside the healthcare setting. Among the limitations of our study was the voluntary nature of participation. Accordingly, the response rate remained rather low, leaving room for bias if HCWs more health conscious and eager to be tested were more/less likely to be seropositive. The study targeted a single-centred cohort and thus may not have represented the general HCW population of the country. Also, the community seroprevalence in El Salvador remains to be elucidated before being conclusive on the major site of SARS-CoV-2 transmission among HCWs, whether within or outside the workplace.
Table 1
Seropositivity rate in healthcare workers of different occupational categories
Occupational category
Seropositive(n = 512)
%
Seronegative(n = 444)
%
Riskratio
pa
Nurse
222
63.8
120
34.5
1.44
<0.0001b
Medical doctor
50
46.7
56
52.3
1.05
0.69
Other patient-related
52
55.9
38
40.9
1.28
0.027
Respiratory care specialist
5
45.5
5
45.5
Radiology personnel
12
52.2
9
39.1
Cleaning staff
23
71.9
9
28.1
Other
12
44.4
15
55.6
Non-patient related
188
44.2
230
54.1
—c
—c
Blood bank personnel
3
21.4
11
78.6
Laboratory professional
26
28.0
65
69.9
Administrative officer
98
51.3
90
47.1
Nutritionist
6
60.0
3
30.0
Pharmacist
17
68.0
8
32.0
Other
38
41.3
53
57.6
χ2 test.
Statistically significant.
Reference group.
Large healthcare-associated outbreaks not only endanger the assurance of quality care in the midst of a pandemic but also may impact the extent and kinetics of spread within the whole society. Alongside occupational exposures, protective measures are ought to target exposures outside the working environment with potential of subsequent introduction into the healthcare setting.Seropositivity rate in healthcare workers of different occupational categoriesχ2 test.Statistically significant.Reference group.
Author's contributions
YNa and MVRF conceptualized the study and performed the formal analyses. RD and YK provided supervision. YNa, MVRF, RD, and KSCM led the investigation. KSCM curated the data and ETK, YNi, and NK validated the outputs of the study. YNa visualised the data and wrote the original draft of the manuscript. MVRF, RD, ETK, NU, AK, and YK reviewed and edited the manuscript. YNa, NU, AK, and YK took parts in funding acquisition.
Transparency declaration
Yu Nakagama and Yasutoshi Kido report ownership of equity of Quantum Molecular Diagnostics, an Osaka City University spinout providing innovative diagnostics for infectious diseases. Yu Nakagama and Yasutoshi Kido also receive financial support outside the work from Abbott Japan, LLC.
Funding
This work was supported by Japan Agency for Medical Research and Development [grant numbers JP20jk0110021 and JP20he1122001]; the Osaka City University Strategic Research Grant 2021 for Young Researchers [grant number OCU-SRG2021_YR09]; Japan Society for the Promotion of Science KAKENHI [grant number 21K09078]; and the Osaka City University Special Reserves Fund for COVID-19.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Silvia Figueiredo Costa; Pedro Giavina-Bianchi; Lewis Buss; Carlos Henrique Mesquita Peres; Mayra Matias Rafael; Lanuse Garcia Neves Dos Santos; Anderson Aparecido Bedin; Maria Cristina Peres Braido Francisco; Fatima Mitie Satakie; Maria Aparecida Jesus Menezes; Ligia Maria Dal Secco; Deyse Mayara Rodrigues Caron; Allan Brum de Oliveira; Matheus Finardi Lima de Faria; Angelica Sauiuri de Aurélio Penteado; Izabel Oliva Marcilio de Souza; Grazielly de Fatima Pereira; Rafael Pereira; Ana Paula Matos Porto; Evelyn Patrícia Sanchez Espinoza; Maria Cassia Mendes-Correa; Carolina Dos Santos Lazari; Jorge Kalil; Maria Beatriz de Moliterno Perondi; Eloisa Silva Dutra de Oliveira Bonfa; Antonio Jose Perreira; Ester Sabino; Alberto José da Silva Duarte; Aluísio Cotrim Segurado; Vera Aparecida Dos Santos; Anna S Levin Journal: Clin Infect Dis Date: 2020-12-13 Impact factor: 9.079
Authors: Jefferson M Jones; Mars Stone; Hasan Sulaeman; Rebecca V Fink; Honey Dave; Matthew E Levy; Clara Di Germanio; Valerie Green; Edward Notari; Paula Saa; Brad J Biggerstaff; Donna Strauss; Debra Kessler; Ralph Vassallo; Rita Reik; Susan Rossmann; Mark Destree; Kim-Anh Nguyen; Merlyn Sayers; Chris Lough; Daniel W Bougie; Megan Ritter; Gerardo Latoni; Billy Weales; Stacy Sime; Jed Gorlin; Nicole E Brown; Carolyn V Gould; Kevin Berney; Tina J Benoit; Maureen J Miller; Dane Freeman; Deeksha Kartik; Alicia M Fry; Eduardo Azziz-Baumgartner; Aron J Hall; Adam MacNeil; Adi V Gundlapalli; Sridhar V Basavaraju; Susan I Gerber; Monica E Patton; Brian Custer; Phillip Williamson; Graham Simmons; Natalie J Thornburg; Steven Kleinman; Susan L Stramer; Jean Opsomer; Michael P Busch Journal: JAMA Date: 2021-10-12 Impact factor: 56.272
Authors: Maura Salaroli de Oliveira; Renata Desordi Lobo; Felippe Pires Detta; José Mauro Vieira Junior; Thiago Lucas de Souza Castro; Daniella Bosco Zambelli; Luiz Francisco Cardoso; Igor Carmo Borges; Tânia Regina Tozetto Mendoza; Silvia Figueiredo Costa; Maria Cassia Mendes Correa Journal: Am J Infect Control Date: 2021-03-24 Impact factor: 2.918
Authors: Roberta Fernandes Correia; Ana Carolina Carioca da Costa; Daniella Campelo Batalha Cox Moore; Saint Clair Gomes Junior; Maria Paula Carneiro de Oliveira; Maria Célia Chaves Zuma; Rômulo Gonçalves Galvani; Wilson Savino; Adriana Cesar Bonomo; Zilton Farias Meira Vasconcelos; Elizabeth Artmann Journal: Lancet Reg Health Am Date: 2021-12-31
Authors: Katie Jeffery; Timothy M Walker; David W Eyre; Sheila F Lumley; Denise O'Donnell; Mark Campbell; Elizabeth Sims; Elaine Lawson; Fiona Warren; Tim James; Stuart Cox; Alison Howarth; George Doherty; Stephanie B Hatch; James Kavanagh; Kevin K Chau; Philip W Fowler; Jeremy Swann; Denis Volk; Fan Yang-Turner; Nicole Stoesser; Philippa C Matthews; Maria Dudareva; Timothy Davies; Robert H Shaw; Leon Peto; Louise O Downs; Alexander Vogt; Ali Amini; Bernadette C Young; Philip George Drennan; Alexander J Mentzer; Donal T Skelly; Fredrik Karpe; Matt J Neville; Monique Andersson; Andrew J Brent; Nicola Jones; Lucas Martins Ferreira; Thomas Christott; Brian D Marsden; Sarah Hoosdally; Richard Cornall; Derrick W Crook; David I Stuart; Gavin Screaton; Timothy Ea Peto; Bruno Holthof; Anne-Marie O'Donnell; Daniel Ebner; Christopher P Conlon Journal: Elife Date: 2020-08-21 Impact factor: 8.713